How many insider declarations does 이지바이오 have?

이지바이오 has filed 1 insider declaration with DART (FSS).

Who is the top reporting insider at 이지바이오?

The top reporting insider at 이지바이오 is 이지바이오, based on the count of public filings.

What is the net insider buy vs sell volume on 이지바이오?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

이

이지바이오: insider trades · South Korea · DART (FSS)

DART:company-4134aaKR·DART (FSS)Mcap 192.2Bn€

AMF ↗

Discover the full management transaction log of 이지바이오, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €192.2bn. The latest transaction was reported on 17 March 2026 — Other. Among the most active insiders: 이지바이오. All data is accessible without an account.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

7100.00 €

Income statement

Revenue476.94 Bn€

Gross profit121.04 Bn€25% margin

Net income27.78 Bn€5.8% margin

Balance sheet & cash

Market cap192.21 Bn€

Total debt152.87 Bn€

Free Cash Flow28.35 Bn€

Last declaration on 17 March 2026

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations